An Open Label, Randomized, Crossover Study To Estimate The Pharmacokinetics And Evaluate The Safety Following A Single Dose Of Azithromycin 2g Extended-Release Powder For Oral Suspension With A 3-Day Dosing Regimen Of Azithromycin 500mg Tablet In Chinese Healthy Male Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 31, 2009

Primary Completion Date

July 31, 2009

Study Completion Date

July 31, 2009

Conditions

Healthy Volunteers

Interventions

DRUG

azithromycin (Zithromax)

"1. a single dose of azithromycin ER 2g~2. 3-day regimen of azithromycin tablet 500mg"

DRUG

azithromycin (Zithromax)

"1. 3-day regimen of azithromycin tablet 500mg~2. a single dose of azithromycin ER 2g"

Trial Locations (1)

Pfizer Investigational Site, Shanghai